Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Thalidomide|DRUG: Capecitabine
Sponsor: SCRI Development Innovations, LLC
Collaborators: Celgene Corporation